Company name: Spot Therapeutics
Description: Provider of cannabis based products.
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
State: New Brunswick
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was acquired by Canopy Growth (TSE: WEED) for CAD 2.25 million on August 28, 2017. Under the terms of the transaction, shareholders of Spot will receive up to CAD2,250,000 in total consideration, less adjustments for all liabilities of Spot as of the closing date and certain payments to be made by Spot between closing and the second tranche payment. At closing, and in satisfaction of the first tranche payment of CAD 1,000,000, Canopy issued 111,669 common shares to the shareholders of Spot. The second tranche payment will be satisfied by the issuance of additional common shares, subject to completion of certain licensing and operational milestones. Closing of the acquisition of the industrial building and property in Fredericton is anticipated to close in early September.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 1.79
Last known valuation date: 28-Aug-2017